Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Lab study: Parkinson’s researchers test a new approach against motor disorders

27.02.2019

Scientists of the German Center for Neurodegenerative Diseases (DZNE) and the University Medical Center Göttingen (UMG) have been able to alleviate motor disorders in mice that resemble those seen in Parkinson’s patients. The rodents were treated with a substance that affects the neurons and immune cells of the brain. If this novel approach proves to be successful in further laboratory studies, it could possibly be tested in clinical trials. The findings are published in “The Journal of Neuroscience”.

In Parkinson’s disease, certain neurons in the brain gradually die off. This so-called “neurodegeneration” has manifold potential consequences that range from serious digestive disorders to dementia.


However, the typical hallmark of Parkinson’s disease is motor impairment, as patients suffer from tremor and stiffness of their arms and legs. Although some of these symptoms can be alleviated, current treatments cannot halt the loss of brain cells. Therefore, there is presently no therapy available to slow down or even stop the course of the disease.

Immune cells of the brain

The current study not only focused on neurons but also on the immune cells of the brain. The latter (called “microglia”) act as a protectant against harmful agents and pathogens. However, in Parkinson’s disease a chronic inflammation develops.

As a result of this persistent immune reaction, the microglia might release metabolites that damage neurons and ultimately cause their death. “We therefore used an experimental drug that was known to have an anti-inflammatory effect,” says Prof. Anja Schneider, head of a research group at the DZNE in Bonn.

“This compound is able to penetrate into the microglia and flip a molecular switch that attenuates the inflammatory reaction. The drug has already been tested in clinical studies on humans as a possible remedy for anxiety disorders. Therefore, data on this substance exists that proves its safety and tolerability in humans.”

Schneider and colleagues in Bonn and Göttingen investigated the effect of this substance called “Emapunil” on mice. These rodents showed movement disorders caused by the loss of neurons in the so-called substantia nigra.

This brain area is also affected in Parkinson’s patients. Treating the mice with Emapunil alleviated the symptoms. “Animals that received the drug had a better command of their motion compared to the untreated animals in a control group,” says Prof. Tiago Outeiro, a researcher at UMG and co-author of the current study.

The scientists identified potential causes. “With our study we were able show that Emapunil has a protective effect on neurons. Different mechanisms appear to be involved”, explains Outeiro. “This drug acts on the microglia and dampens inflammatory reactions. Basically, this was already known. However, we now discovered that the compound also affects neurons directly. Especially in these cells Emapunil reduces the so-called unfolded protein response. This is a stress reaction that can lead to cell death.”

A molecular receptor

From previous investigations it was already known that Emapunil binds to a molecule called TSPO (translocator protein). This receptor is expressed in neurons and microglia. “Our results suggest that TSPO could basically be a target for drugs against neurodegenerative diseases,” says Prof. Markus Zweckstetter, a scientist at the DZNE’s Göttingen site and at the Max Planck Institute for Biophysical Chemistry.

The researchers propose to further investigate involved mechanisms. “In the lab only partial aspects of Parkinson’s disease can be simulated,” DZNE scientist Schneider says. “Therefore, we would like to suggest that the current results be tested in further laboratory studies and using other disease models. If acting upon TSPO proves to be successful, this strategy could be tested in clinical studies on Parkinson’s disease.”

Media contact
Dr. Marcus Neitzert
Science Editor & Acting Deputy Head
marcus.neitzert@dzne.de

+49 228 43302-267


Original publication

Translocator protein ligand protects against neurodegeneration in the MPTP mouse model of Parkinsonism
Jing Gong, Eva M. Szego et al. (2019).JNeurosci.
DOI: 10.1523/JNEUROSCI.2070-18.2019

German version: https://www.dzne.de/aktuelles/presse-und-oeffentlichkeitsarbeit/pressemitteilung...

Dr. Marcus Neitzert | idw - Informationsdienst Wissenschaft
Further information:
https://www.dzne.de/en/news/public-relations/press-releases/press/detail/lab-study-parkinsons-researchers-test-a-new-approach-against-motor-disorders/

More articles from Life Sciences:

nachricht To proliferate or not to proliferate
21.03.2019 | Max-Planck-Institut für molekulare Zellbiologie und Genetik

nachricht Discovery of a Primordial Metabolism in Microbes
21.03.2019 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Magnetic micro-boats

Nano- and microtechnology are promising candidates not only for medical applications such as drug delivery but also for the creation of little robots or flexible integrated sensors. Scientists from the Max Planck Institute for Polymer Research (MPI-P) have created magnetic microparticles, with a newly developed method, that could pave the way for building micro-motors or guiding drugs in the human body to a target, like a tumor. The preparation of such structures as well as their remote-control can be regulated using magnetic fields and therefore can find application in an array of domains.

The magnetic properties of a material control how this material responds to the presence of a magnetic field. Iron oxide is the main component of rust but also...

Im Focus: Self-healing coating made of corn starch makes small scratches disappear through heat

Due to the special arrangement of its molecules, a new coating made of corn starch is able to repair small scratches by itself through heat: The cross-linking via ring-shaped molecules makes the material mobile, so that it compensates for the scratches and these disappear again.

Superficial micro-scratches on the car body or on other high-gloss surfaces are harmless, but annoying. Especially in the luxury segment such surfaces are...

Im Focus: Stellar cartography

The Potsdam Echelle Polarimetric and Spectroscopic Instrument (PEPSI) at the Large Binocular Telescope (LBT) in Arizona released its first image of the surface magnetic field of another star. In a paper in the European journal Astronomy & Astrophysics, the PEPSI team presents a Zeeman- Doppler-Image of the surface of the magnetically active star II Pegasi.

A special technique allows astronomers to resolve the surfaces of faraway stars. Those are otherwise only seen as point sources, even in the largest telescopes...

Im Focus: Heading towards a tsunami of light

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.

"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...

Im Focus: Revealing the secret of the vacuum for the first time

New research group at the University of Jena combines theory and experiment to demonstrate for the first time certain physical processes in a quantum vacuum

For most people, a vacuum is an empty space. Quantum physics, on the other hand, assumes that even in this lowest-energy state, particles and antiparticles...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International Modelica Conference with 330 visitors from 21 countries at OTH Regensburg

11.03.2019 | Event News

Selection Completed: 580 Young Scientists from 88 Countries at the Lindau Nobel Laureate Meeting

01.03.2019 | Event News

LightMAT 2019 – 3rd International Conference on Light Materials – Science and Technology

28.02.2019 | Event News

 
Latest News

To proliferate or not to proliferate

21.03.2019 | Life Sciences

Magnetic micro-boats

21.03.2019 | Physics and Astronomy

Motorless pumps and self-regulating valves made from ultrathin film

21.03.2019 | HANNOVER MESSE

VideoLinks
Science & Research
Overview of more VideoLinks >>>